Rand Capital
Rand Capital Corporation :: Home.
Buffalo New York (HQ)
Financials
Estimates*
USD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | <1m | <1m | (<1m) | 3.0m | 20.8m | (<1m) | 9.3m |
% growth | - | (1 %) | (175 %) | (511 %) | 584 % | (102 %) | (2222 %) |
EBITDA | (<1m) | <1m | <1m | 2.0m | (2.0m) | - | - |
% EBITDA margin | (22 %) | 26 % | (54 %) | 66 % | (10 %) | - | - |
Profit | (<1m) | (<1m) | (2.3m) | <1m | 15.8m | (<1m) | 6.5m |
% profit margin | (71 %) | (40 %) | 310 % | 24 % | 76 % | 202 % | 70 % |
EV / revenue | 20.8x | 20.6x | -32.9x | 11.8x | 2.1x | -81.5x | 5.0x |
EV / EBITDA | -96.4x | 80.0x | 60.8x | 18.0x | -21.5x | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
N/A | $25.0m | Post IPO Equity | |
N/A | $4.5m | Post IPO Equity | |
* | N/A | $25.0m | Post IPO Debt |
Total Funding | - |
Recent News about Rand Capital
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
By Country
By Industry
Investments by Rand Capital
EditACQUISITION by Athenex Sep 2014
ACQUISITION by Biocare Medical Nov 2022
ACQUISITION by BMC Dec 2010
ACQUISITION by Towers Watson Nov 2013
BUYOUT by Centre Lane Partners Feb 2021